Literature DB >> 11397506

Current research on respiratory viral infections: Third International Symposium.

A C Schmidt1, R B Couch, G J Galasso, F G Hayden, J Mills, B R Murphy, R M Chanock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11397506      PMCID： PMC7133842          DOI： 10.1016/s0166-3542(01)00136-x

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  146 in total

1.  Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.

Authors:  M Sorrentino; T Powers
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

2.  Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.

Authors:  Y Li; J Kang; M S Horwitz
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 3.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

4.  A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein.

Authors:  M J van Raaij; A Mitraki; G Lavigne; S Cusack
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

5.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion.

Authors:  F W Henderson; A M Collier; M A Sanyal; J M Watkins; D L Fairclough; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

7.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

Authors:  J A Englund; P A Piedra; A Jewell; K Patel; B B Baxter; E Whimbey
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats.

Authors:  P R Wyde; D K Moore-Poveda; B O'Hara; W D Ding; B Mitsner; B E Gilbert
Journal:  Antiviral Res       Date:  1998-04       Impact factor: 5.970

9.  Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".

Authors:  C D Marchant; S A Carlin; C E Johnson; P A Shurin
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

10.  Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season.

Authors:  C D Brandt; H W Kim; B C Jeffries; G Pyles; E E Christmas; J L Reid; R M Chanock; R H Parrott
Journal:  Am J Epidemiol       Date:  1972-03       Impact factor: 4.897
View more
  9 in total

1.  Reduced clearance of respiratory syncytial virus infection in a preterm lamb model.

Authors:  David K Meyerholz; Branka Grubor; Sasha J Fach; Randy E Sacco; Howard D Lehmkuhl; Jack M Gallup; Mark R Ackermann
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

2.  Respiratory syncytial virus vaccine: Is it coming?

Authors:  Valérie Sales; Elaine El Wang
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

Review 3.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

4.  Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection.

Authors:  Cariosa M Noone; Elaine Paget; Ellen A Lewis; Marius R Loetscher; Robert W Newman; Patricia A Johnson
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

5.  Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.

Authors:  James J McSharry; Ann C McDonough; Betty A Olson; George L Drusano
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

6.  Orally active fusion inhibitor of respiratory syncytial virus.

Authors:  Christopher Cianci; Kuo-Long Yu; Keith Combrink; Ny Sin; Bradley Pearce; Alan Wang; Rita Civiello; Stacey Voss; Guangxiang Luo; Kathy Kadow; Eugene V Genovesi; Brian Venables; Hatice Gulgeze; Ashok Trehan; Jennifer James; Lucinda Lamb; Ivette Medina; Julia Roach; Zheng Yang; Lisa Zadjura; Richard Colonno; Junius Clark; Nicholas Meanwell; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

7.  Current research on respiratory viral infections: Fifth International Symposium.

Authors:  Michael G Ison; Sebastian L Johnston; Peter Openshaw; Brian Murphy; Frederick Hayden
Journal:  Antiviral Res       Date:  2004-06       Impact factor: 5.970

Review 8.  Immunoprophylaxis of respiratory syncytial virus: global experience.

Authors:  Eric A F Simoes
Journal:  Respir Res       Date:  2002

Review 9.  Treatment of respiratory virus infections.

Authors:  Yacine Abed; Guy Boivin
Journal:  Antiviral Res       Date:  2006-02-14       Impact factor: 5.970
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.